Cognitive Vulnerability in the Elderly Patients with Depression: Who is at Risk?
Abstract
Background. Depression among the elderly is one of the main causes of global disability and a decline in the quality of life. Late-life depressions often accompany cognitive impairments, which can persist after the end of the depressive phase. The identification of clinico-biological predictors of the development and progression of cognitive disorders is an urgent problem of modern research.
Objective — to study the influence of clinical and biological characteristics of patients with late-onset depression on cognitive functioning (clinical and follow-up study).
Material and methods. 51 patients aged 60 years and older with late-life depression who were treated in a gerontopsychiatric hospital were re-examined after 1 and 3 years. By the end of the inpatient treatment period, two groups of patients were identified: group 1 — without cognitive impairment in the structure of depression — 38 participants (74.5 %) and group 2 — 13 participants (25.5 %) — with subjective complaints of memory impairment. Subsequently, a comparative prospective follow-up of patients from the selected groups was carried out. The examination was conducted using clinical-psychopathological, psychometric, immunological and statistical methods and clinical follow-up.
Results. Patients with cognitive impairment (group 2), compared with group 1, differed in age at the time of examination (73.4 ± 7.7 and 67.8 ± 5.9 years, respectively, p < 0.05), the psychopathological structure of depression (depression with predominant negative affectivity occurred in 76.9 and 55.3 % of cases, respectively, p < 0.05), the burden of multiple comorbidities, including cardiac pathology (100 and 76.3 % of cases, respectively, p < 0.05), lower efficacy of therapy (p < 0.001). In addition, the compared groups differed in immunological characteristics: all patients with complaints of memory impairment belonged to immunophenotype 2 (with reduced activity of leukocyte elastase and its protease inhibitor).
Conclusion. The study revealed a high risk of cognitive impairment in elderly patients with depression, which was associated with certain clinical and biological characteristics. The study revealed the following predictors of cognitive decline: the older age of patients, the predominance of negative affectivity in the structure of depression, multiple comorbidities, incomplete remissions, and features of the immune status.
Keywords
depression, cognitive functioning, clinical and biological features, older age, predictors of cognitive decline
References
- Huang C., Fang Y., Yan F. et al. Efficacy of problem-solving therapy in treating late-life depression with potential cognitive impairment: A systematic review and meta-analysis // BMJ Open. – 2024. – Vol. 14, № 10. – e084130. – https://doi.org/10.1136/bmjopen-2024-084130
- Rhee T.G., Shim S.R., Manning K.J. et al. Neuropsychological assessments of cognitive impairment in major depressive disorder: A systematic review and meta-analysis with metaregression // Psychotherapy and Psychosomatics. – 2024. – Vol. 93. – Pp. 8–23. – https://doi.org/10.1159/000535665
- Knight M.J., Baune B.T. Cognitive dysfunction in major depressive disorder // Current Opinion in Psychiatry. – 2018. – Vol. 31. – Pp. 26–31. – https://doi.org/10.1097/YCO.0000000000000378
- Siddarth P., Funes C.M., Laird K.T. et al. Predictors of cognitive improvement following treatment for late-life depression // Journal of Geriatric Psychiatry and Neurology. – 2021. – Vol. 34. – Pp. 162–168. – https://doi.org/10.1177/0891988720915515
- Koenig A.M., Bhalla R.K., Butters M.A. Cognitive functioning and late-life depression // Journal of the International Neuropsychological Society. – 2014. – Vol. 20, № 5. – Pp. 461–467. – https://doi.org/10.1017/S1355617714000198
- Сафарова Т.П., Яковлева О.Б., Андросова Л.В. и др. Некоторые факторы воспаления и иммунофенотипы при депрессиях у пожилых больных // Журнал неврологии и психиатрии имени С.С. Корсакова. – 2020. – № 120 (2). – С. 53–58. – https://doi.org/10.17116/jnevro202012002153
- Safarova T.P., Yakovleva O.B., Androsova L.V. et al. Nekotorye faktory vospaleniya i immunofenotipy pri depressiyakh u pozhilykh bol’nykh // Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. – 2020. – № 120 (2). – S. 53–58. – https://doi.org/10.17116/jnevro202012002153
- Смулевич А.Б. Депрессии при соматических и психических заболеваниях. – М.: Медицинское информационное агентство, 2003. – 432 с.
- Smulevich A.B. Depressii pri somaticheskikh i psikhicheskikh zabolevaniyakh. – M.: Meditsinskoe informatsionnoe agentstvo, 2003. – 432 s.
- Frank E., Prien R.F., Jarrett R.B., Keller M.D., Kupfer D.J., Lavori P.W., Rush A.J., Weissman M.M. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence // Archives of General Psychiatry. – 1991. – Vol. 48, № 9. – Pp. 851–855. – https://doi.org/10.1001/archpsyc.1991.01810330075011
- Wiels W., Baeken C., Engelborghs S. Depressive symptoms in the elderly – an early symptom of dementia? A systematic review // Frontiers in Pharmacology. – 2020. – Vol. 11. – Art. 3422. – https://doi.org/10.3389/fphar.2020.0003422
- Kaup A.R., Byers A.L., Falvey C. et al. Trajectories of depressive symptoms in older adults and risk of dementia // JAMA Psychiatry. – 2016. – Vol. 73, № 5. – Pp. 525–531. – https://doi.org/10.1001/jamapsychiatry.2016.0004
- Panza F., Frisardi V., Capurso C. et al. Late-life depression, mild cognitive impairment, and dementia: Possible continuum? // American Journal of Geriatric Psychiatry. – 2010. – Vol. 18, № 2. – Pp. 98–116. – https://doi.org/10.1097/JGP.0b013e3181b0fa13
- Mourao R.J., Mansur G., Malloy-Diniz L.F. et al. Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: Systematic review and meta-analysis // International Journal of Geriatric Psychiatry. – 2016. – Vol. 31, № 8. – Pp. 905–911. – https://doi.org/10.1002/gps.4406
- Vares E.A., Salum G.A., Spanemberg L. et al. Depression dimensions: Integrating clinical signs and symptoms from the perspectives of clinicians and patients // PLoS ONE. – 2015. – Vol. 10, № 8. – e0136037. – https://doi.org/10.1371/journal.pone.0136037
- Lanctot K.L., Agüera-Ortiz L., Brodaty H. et al. Apathy associated with neurocognitive disorders: Recent progress and future directions // Alzheimer's & Dementia. – 2017. – Vol. 13, № 1. – Pp. 84–100. – https://doi.org/10.1016/j.jalz.2016.05.008
- Montoya-Murillo G., Ibarretxe-Bilbao N., Pena J. et al. The impact of apathy on cognitive performance in the elderly // International Journal of Geriatric Psychiatry. – 2019. – Vol. 34, № 5. – Pp. 657–665. – https://doi.org/10.1002/gps.5062
- Li N., Chen G., Zeng P. et al. Prevalence and factors associated with mild cognitive impairment among Chinese older adults with depression // Geriatrics & Gerontology International. – 2018. – Vol. 18, № 2. – Pp. 263–268. – https://doi.org/10.1111/ggi.13171
- Wu Z., Su G., Lu W. et al. Clinical symptoms and their relationship with cognitive impairment in elderly patients with depressive disorder // Frontiers in Psychiatry. – 2022. – Vol. 13. – Art. 1009653. – https://doi.org/10.3389/fpsyt.2022.1009653
- Zhong X., Wu Z., Ouyang C. et al. Cardiovascular diseases and related risk factors accelerated cognitive deterioration in patients with late-life depression: A one-year prospective study // International Psychogeriatrics. – 2019. – Vol. 31, № 10. – Pp. 1483–1489. – https://doi.org/10.1017/S1041610218002041
- Wu A., Zhang J. Neuroinflammation, memory, and depression: New approaches to hippocampal neurogenesis // Journal of Neuroinflammation. – 2023. – Vol. 20, № 1. – Art. 283. – https://doi.org/10.1186/s12974-023-02964-x
- Jiang P., Gao Y., Wang L. et al. Factors influencing cognitive function in elderly patients with late-life depression: A scoping review // Brain and Behavior. – 2025. – Vol. 15, № 1. – e70265. – https://doi.org/10.1002/brb3.70265
- Касьянова А.А., Лиманкин О.В., Петрова Н.Н. Противовоспалительная терапия биполярного аффективного расстройства: текущий уровень доказательств // Современная терапия психических расстройств. – 2025. – № 1. – С. 24–32. – https://doi.org/10.48612/psyph/p3n7-t14h-zdea
- Kas’yanova A.A., Limankin O.V., Petrova N.N. Protivovospalitel’naya terapiya bipolyarnogo affektivnogo rasstroystva: tekushchiy uroven’ dokazatel’stv // Sovremennaya terapiya psikhicheskikh rasstroystv. – 2025. – № 1. – S. 24–32. – https://doi.org/10.48612/psyph/p3n7-t14h-zdea
- Янушко М.Г., Шаманина М.В. Факторы нейровоспаления и когнитивный дефицит при рекуррентной депрессии: поиски патогенетических и терапевтических мишеней // Современная терапия психических расстройств. – 2024. – № 4. – С. 22–28. – https://doi.org/10.21265/PSYPH.2024.61.34.003
- Yanushko M.G., Shamanina M.V. Faktory neyrovosпалeniya i kognitivnyy defitsit pri rekurrentnoy depressii: poiski patogeneticheskikh i terapevticheskikh misheney // Sovremennaya terapiya psikhicheskikh rasstroystv. – 2024. – № 4. – S. 22–28. – https://doi.org/10.21265/PSYPH.2024.61.34.003
- Mars J.A., Marwaha R. Depressive cognitive disorders // StatPearls [Internet]. – Treasure Island (FL): StatPearls Publishing, 2025. – PMID: 32644682
